TRIAMINIC EXPECTORANT DH SYRUP Sirop
Country: Canada
Language: French
Source: Health Canada
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
Chlorhydrate de phénylpropanolamine; Maléate de phéniramine; Maléate de pyrilamine; Guaïfénésine; Bitartrate d'hydrocodone
Available from:
NOVARTIS CONSUMER HEALTH CANADA INC.
ATC code:
R05FA02
INN (International Name):
OPIUM DERIVATIVES AND EXPECTORANTS
Dosage:
12.5MG; 6.25MG; 6.25MG; 100MG; 1.67MG
Pharmaceutical form:
Sirop
Composition:
Chlorhydrate de phénylpropanolamine 12.5MG; Maléate de phéniramine 6.25MG; Maléate de pyrilamine 6.25MG; Guaïfénésine 100MG; Bitartrate d'hydrocodone 1.67MG
Administration route:
Orale
Units in package:
500ML
Prescription type:
Stupéfiant (LRCDAS I)
Therapeutic area:
ANTITUSSIVES
Product summary:
Numéro de groupe d'ingrédients actifs (GIA) :0503200001; AHFS:
Authorization status:
ANNULÉ APRÈS COMMERCIALISATION
Authorization date:
2001-04-06
